✦ LIBER ✦

Targeting Histone Deacetylase in Cancer Therapy

✍ Scribed by Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen

Publisher: John Wiley and Sons
Year: 2006
Weight: 8 KB
Volume: 37
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200638252

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

📜 SIMILAR VOLUMES

Targeting histone deacetylase in cancer

Targeting histone deacetylase in cancer therapy

✍ Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB

## Abstract Histone deacetylase (HDAC) is recognized as one of the promising targets for cancer treatment as many HDAC inhibitors have entered clinical trials for both solid and liquid tumors. Nevertheless, the mechanisms underlying the antiproliferative effects of HDAC inhibitors remain elusive. A

Targeting epigenetic abnormalities with

Targeting epigenetic abnormalities with histone deacetylase inhibitors

✍ Barbara A. Conley; John J. Wright; Shivaani Kummar 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

Targeting histone deacetylases for the t

Targeting histone deacetylases for the treatment of cancer and inflammatory diseases

✍ Lili Huang 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

## Abstract Histone deacetylases (HDACs) are involved in chromatin remodeling and modification of nonhistone transcription regulatory proteins, thus modulating the expression of genes important for complex biological events. Dysregulation of HDACs and aberrant chromatin acetylation and deacetylatio

Histone deacetylases, transcriptional co

Histone deacetylases, transcriptional control, and cancer

✍ W. Douglas Cress; Edward Seto 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

A key event in the regulation of eukaryotic gene expression is the posttranslational modification of nucleosomal histones, which converts regions of chromosomes into transcriptionally active or inactive chromatin. The most well studied posttranslational modification of histones is the acetylation of

Molecularly Targeted Approach to Cancer

Molecularly Targeted Approach to Cancer Therapy: Design, Synthesis and Biological Activity of Non-Hydroxamate Histone Deacetylase Inhibitors

✍ Takayoshi Suzuki; Hidehiko Nakagawa; Naoki Miyata 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB 👁 2 views

Thioredoxin in Cancer — The Role of Hist

Thioredoxin in Cancer — The Role of Histone Deacetylase Inhibitors

✍ Paul A. Marks 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 11 KB 👁 1 views